Selected article for: "patient secondary infection and secondary infection"
Author: Naeh, Amir; Berezowsky, Alexandra; Yudin, Mark H.; Dhalla, Irfan A.; Berger, Howard
Title: Preeclampsia-like syndrome in a pregnant patient with Coronavirus Disease 2019 (COVID-19)
  • Cord-id: tb2ida6n
  • Document date: 2021_10_12
    • ID: tb2ida6n
    Snippet: Background Hypertension, proteinuria, and hepatic dysfunction have been described as manifestations of coronavirus disease 2019 (COVID-19) and are generally accepted as poor prognostic factors. However, these same findings can also occur in pregnant women with preeclampsia, thus creating a diagnostic challenge. Case We report a case of COVID-19 infection in an otherwise healthy pregnant patient with secondary hypertension, proteinuria, and significant hepatic dysfunction. Maternal placental grow
    Document: Background Hypertension, proteinuria, and hepatic dysfunction have been described as manifestations of coronavirus disease 2019 (COVID-19) and are generally accepted as poor prognostic factors. However, these same findings can also occur in pregnant women with preeclampsia, thus creating a diagnostic challenge. Case We report a case of COVID-19 infection in an otherwise healthy pregnant patient with secondary hypertension, proteinuria, and significant hepatic dysfunction. Maternal placental growth factor (PlGF) testing was used to rule out preeclampsia. The patient received supportive care and improved significantly. She went on to have a spontaneous vaginal term delivery of a healthy male baby. Conclusion COVID-19 infection in pregnancy may present as preeclampsia-like syndrome. PlGF testing can be used to differentiate preeclampsia from COVID-19 and facilitate appropriate management.

    Search related documents:
    Co phrase search for related documents
    • additional study and admission prior: 1
    • admission icu mechanical ventilation and low molecular weight heparin: 1, 2, 3, 4, 5
    • admission icu mechanical ventilation and low molecular weight heparin prophylactic dose: 1
    • admission icu mechanical ventilation severe disease and low molecular weight heparin: 1
    • admission prior and low molecular weight heparin: 1, 2
    • low molecular weight heparin and magnesium sulfate: 1